1. Home
  2. EDIT vs ALLT Comparison

EDIT vs ALLT Comparison

Compare EDIT & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.91

Market Cap

310.9M

Sector

Health Care

ML Signal

HOLD

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$7.50

Market Cap

364.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDIT
ALLT
Founded
2013
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
310.9M
364.0M
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
EDIT
ALLT
Price
$2.91
$7.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$5.30
$12.40
AVG Volume (30 Days)
1.3M
309.2K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
N/A
EPS
N/A
N/A
Revenue
$31,937,000.00
N/A
Revenue This Year
N/A
$15.84
Revenue Next Year
N/A
$12.09
P/E Ratio
N/A
$469.21
Revenue Growth
132.64
N/A
52 Week Low
$1.43
$6.12
52 Week High
$4.54
$11.92

Technical Indicators

Market Signals
Indicator
EDIT
ALLT
Relative Strength Index (RSI) 48.07 50.60
Support Level $2.77 $7.52
Resistance Level $3.17 $8.26
Average True Range (ATR) 0.22 0.37
MACD -0.04 0.05
Stochastic Oscillator 28.00 29.68

Price Performance

Historical Comparison
EDIT
ALLT

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: